These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 21837360

  • 1. Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs.
    Chen QY, Xu LQ, Jiao DM, Yao QH, Wang YY, Hu HZ, Wu YQ, Song J, Yan J, Wu LJ.
    Int J Mol Med; 2011 Nov; 28(5):769-76. PubMed ID: 21837360
    [Abstract] [Full Text] [Related]

  • 2. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
    Chen QY, Jiao DM, Yao QH, Yan J, Song J, Chen FY, Lu GH, Zhou JY.
    Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer.
    Yuan K, Qian C, Zheng R.
    Med Sci Monit; 2009 Nov; 15(11):BR313-9. PubMed ID: 19865048
    [Abstract] [Full Text] [Related]

  • 4. Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway.
    Chen QY, Zheng Y, Jiao DM, Chen FY, Hu HZ, Wu YQ, Song J, Yan J, Wu LJ, Lv GY.
    J Nutr Biochem; 2014 Feb; 25(2):177-85. PubMed ID: 24445042
    [Abstract] [Full Text] [Related]

  • 5. Prognostic role of integrin β1, E-cadherin, and rac1 expression in small cell lung cancer.
    Chang MH, Lee K, Lee KY, Kim YS, Kim YK, Kang JH.
    APMIS; 2012 Jan; 120(1):28-38. PubMed ID: 22151306
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of CRKII increases migration and invasive potential in oral squamous cell carcinoma.
    Yamada S, Yanamoto S, Kawasaki G, Rokutanda S, Yonezawa H, Kawakita A, Nemoto TK.
    Cancer Lett; 2011 Apr 28; 303(2):84-91. PubMed ID: 21339045
    [Abstract] [Full Text] [Related]

  • 7. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ, Taschereau EO, Koegel AK, Ginther CL, Rotow JK, Isfahani KZ, Slamon DJ.
    Lung Cancer; 2010 Dec 28; 70(3):253-62. PubMed ID: 20338664
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
    Yap LF, Jenei V, Robinson CM, Moutasim K, Benn TM, Threadgold SP, Lopes V, Wei W, Thomas GJ, Paterson IC.
    Oncogene; 2009 Jul 09; 28(27):2524-34. PubMed ID: 19448673
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
    Zhu X, Gao G, Chu K, Yang X, Ren S, Li Y, Wu H, Huang Y, Zhou C.
    Int J Biochem Cell Biol; 2015 Apr 09; 61():103-14. PubMed ID: 25687035
    [Abstract] [Full Text] [Related]

  • 10. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.
    Zhao H, Jiao Y, Zhang Z.
    Int J Clin Exp Pathol; 2015 Apr 09; 8(12):15582-90. PubMed ID: 26884827
    [Abstract] [Full Text] [Related]

  • 11. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
    Han G, Fan B, Zhang Y, Zhou X, Wang Y, Dong H, Wei Y, Sun S, Hu M, Zhang J, Wei L.
    Oncol Rep; 2008 Oct 09; 20(4):929-39. PubMed ID: 18813837
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 09; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 13. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y.
    Eur J Cancer; 2011 Oct 09; 47(15):2353-63. PubMed ID: 21680174
    [Abstract] [Full Text] [Related]

  • 14. Vasodilator-stimulated phosphoprotein regulates osteosarcoma cell migration.
    Wu G, Wei L, Yu A, Zhang M, Qi B, Su K, Hu X, Wang J.
    Oncol Rep; 2011 Dec 09; 26(6):1609-15. PubMed ID: 21874265
    [Abstract] [Full Text] [Related]

  • 15. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells.
    Ip CK, Cheung AN, Ngan HY, Wong AS.
    Oncogene; 2011 May 26; 30(21):2420-32. PubMed ID: 21258406
    [Abstract] [Full Text] [Related]

  • 16. PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells.
    Zanca C, Cozzolino F, Quintavalle C, Di Costanzo S, Ricci-Vitiani L, Santoriello M, Monti M, Pucci P, Condorelli G.
    J Cell Physiol; 2010 Oct 26; 225(1):63-72. PubMed ID: 20648624
    [Abstract] [Full Text] [Related]

  • 17. Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton.
    Li X, Law JW, Lee AY.
    Oncogene; 2012 Feb 02; 31(5):595-610. PubMed ID: 21706053
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
    Lee YC, Lin HH, Hsu CH, Wang CJ, Chiang TA, Chen JH.
    Eur J Pharmacol; 2010 Apr 25; 632(1-3):23-32. PubMed ID: 20097193
    [Abstract] [Full Text] [Related]

  • 19. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma.
    Yamada S, Yanamoto S, Yoshida H, Yoshitomi I, Kawasaki G, Mizuno A, Nemoto TK.
    Int J Oral Maxillofac Surg; 2010 Jan 25; 39(1):61-7. PubMed ID: 19913389
    [Abstract] [Full Text] [Related]

  • 20. Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach.
    Vader P, van der Meel R, Symons MH, Fens MH, Pieters E, Wilschut KJ, Storm G, Jarzabek M, Gallagher WM, Schiffelers RM, Byrne AT.
    Angiogenesis; 2011 Dec 25; 14(4):457-66. PubMed ID: 21789714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.